Anticoagulation. Current approach to heparin and warfarin therapy

Area of Science:

• Pharmacology
• Internal Medicine
• Hematology

Background:

• Anticoagulant therapy is essential for numerous medical indications.
• Heparin is the primary choice for acute anticoagulation, administered intravenously and monitored using partial thromboplastin time.
• Long-term anticoagulation typically involves initial heparin infusion followed by oral warfarin, with prothrombin time monitoring.

Purpose of the Study:

• To outline the standard protocols for anticoagulant therapy.
• To emphasize the importance of monitoring therapeutic anticoagulation.
• To highlight the critical complication of bleeding and its management.

Main Methods:

• Review of established anticoagulant treatment regimens.
• Description of monitoring parameters: partial thromboplastin time for heparin and prothrombin time for warfarin.
• Identification of risk factors and reversal strategies for anticoagulant-induced bleeding.

Main Results:

• Standard regimens involve intravenous heparin followed by oral warfarin for long-term anticoagulation.
• Therapeutic anticoagulation requires vigilant monitoring via specific laboratory tests.
• Bleeding is the most significant adverse event associated with anticoagulant use.

Conclusions:

• Physicians must understand the indications, monitoring, and duration of anticoagulant therapy.
• Awareness of bleeding risks and knowledge of reversal agents are paramount for safe patient care.
• Effective management of anticoagulation balances therapeutic benefits with the potential for serious complications.